Navigation Links
JumpStart Invests in Checkpoint Surgical
Date:11/10/2009

CLEVELAND, Nov. 10 /PRNewswire/ -- JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, announced a JumpStart Ventures investment commitment of $250,000 in Checkpoint Surgical, LLC. A spinout of NDI Medical, the Highland Hills, OH medical device company is developing and commercializing a surgical handheld disposable nerve stimulator.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060209/CLJUMPSTARTLOGO )

Nerve stimulators are used to locate, identify, and confirm motor nerve function and help surgeons avoid nerve damage during surgical procedures. Checkpoint Surgical's device, called the CHECKPOINT® Stimulator/Locator, combines the broad functionality of traditional console-based devices with the convenience and control of a handheld device.

"Right now, there is no device on the market that combines the broad functionality of console-based devices with the control of a handheld device," said Lee Poseidon, the JumpStart Venture Partner who will be working with the company. "Checkpoint Surgical has several patents pending around the use of a safe, biphasic current, handheld device with broad, adjustable stimulus parameters, which will give their product competitive advantage."

"The CHECKPOINT® Stimulator/Locator is an important tool that helps surgeons quickly and reliably locate nerves and evaluate nerve function during surgery. With the aid of our tool, physicians can make surgical decisions with confidence. It also allows surgeons to reliably confirm and document nerve integrity at the conclusion of surgery," said Len Cosentino, Chief Executive Officer of Checkpoint Surgical. "JumpStart's funding will help support our pilot launch effort that will demonstrate market acceptance and provide other useful market data over the next few months leading up to a full commercial launch in mid 2010."

This is JumpStart Ventures' 54th investment in its 41st company. Other healthcare companies in JumpStart Ventures' portfolio include AnalizaDx, CardioInsight Technologies, CerviLenz, Freedom Meditech, Great Lakes Pharmaceuticals, Juventas Therapeutics, Neuros Medical, Synapse Biomedical, Tursiop Technologies, and VasoLux MicroSystems.

About Checkpoint Surgical LLC

The mission of Checkpoint Surgical (www.checkpointsurgical.com) is to provide physicians with medical devices to locate, evaluate and protect nerves and muscles in surgical procedures for better patient outcomes. The Company's flagship product, the CHECKPOINT® Stimulator/Locator is a single-use, hand-held stimulator with a broad range of stimulation parameters that are fully controllable by the surgeon. The CHECKPOINT® Stimulator/Locator was designed by a world class team of orthopaedic surgeons and biomedical engineers working together to provide surgeons with a simple, safe, versatile tool to help locate, identify and evaluate nerves in the surgical site and make surgical decisions with confidence. Beyond this initial product, the Checkpoint surgical team is dedicated to continue to develop new and innovative first in class devices to help surgeons achieve better patient outcomes.

About JumpStart Inc.

JumpStart (www.jumpstartinc.org) is a nationally recognized venture development organization that accelerates the progress of high potential, early-stage businesses and includes a special focus on diverse entrepreneurs working in the highest growth industries. Through the depth of its entrepreneurial team and the breadth of its high value resources, JumpStart improves client success in achieving significant milestones, including raising the follow-on capital necessary to create wealth. JumpStart strives to create a more prosperous future for Northeast Ohio. As part of its robust public/private partnership model, JumpStart recognizes the integral support of Ohio's Third Frontier Project, the state's largest-ever commitment to expanding Ohio's high tech research, innovation, commercialization, and company formation activities, which are increasing opportunities for all Ohioans.

SOURCE JumpStart, Inc.


'/>"/>
SOURCE JumpStart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
2. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
3. 7 Health Ventures Invests in Tulip Medical
4. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
5. Merial invests US $70 million in Nanchang, China
6. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
9. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
10. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
11. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... AMSTERDAM , December 8, 2016 Information ... TM metrics in Scopus , the world,s largest ... free access to comprehensive metrics for journals from over 5,000 publishers. ... publish, which journals to subscribe to and when to adjust a ... , , ...
(Date:12/8/2016)... 2016 According to the research report, ... is expected to be worth US$9.7 bn by the ... Between the forecast years of 2016 and 2024, the global ... The leading players operating in the global diabetes injection pens ... plc., Biocon Ltd., and Sanofi S.A. Transparency Market Research reports ...
(Date:12/8/2016)... 2016 According to a new market research report ... Therapeutic (Pain, Insulin)), End Use (Sports, Fitness, RPM), Type (Smart watch, Patch), ... global market, in terms of value, is projected to reach 12.14 Billion ... 18.0% during the forecast period. Continue Reading ... ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged to ... mind, SIGVARIS has created a new line of anti-embolism stockings to help prevent ... the benefits of graduated compression when transitioning from recovery to early rehabilitation. , ...
Breaking Medicine News(10 mins):